Synthesis of 2-(1,1-dicyanopropen-2-yl)-6-(2-[18F]-fluoroethyl)-methylamino-naphthalene ([18F]FDDNP)

Applied Radiation and Isotopes

Volumn 66, Issue 2, 2008, Pages 203-207

  Klok, R P ^a   Klein, P J ^a   van Berckel, B N M ^a   Tolboom, N ^a   Lammertsma, A A ^a   Windhorst, A D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amyloid; 18F FDDNP; Alzheimer disease; F 18; Positron emission tomography

Indexed keywords

ALZHEIMER DISEASES; ASCORBIC ACID SOLUTION; RADIOCHEMICAL PURITY;

ACETONITRILE; FLUORINATION; POSITRON EMISSION TOMOGRAPHY; PURIFICATION; SYNTHESIS (CHEMICAL); YIELD STRESS;

NAPHTHALENE;

2 (1,1 DICYANOPROPEN 2 YL) 6 (2 FLUOROETHYL)METHYLAMINO NAPHTHALENE F 18; ACETONITRILE; ASCORBIC ACID; PYROGEN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG SYNTHESIS; FLUORINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; SOLID PHASE EXTRACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORINE RADIOISOTOPES; HUMANS; NITRILES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 37149032276     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2007.10.008     Document Type: Article

References (13)

1. Agdeppa ED., Kepe V., Liu J., Flores-Torres S., Satyamurthy N., Petric A., Cole GM., Small GW., Huang SC., and Barrio JR. Binding charcteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer's disease. J. Neurosci. 21 RC189 (2001) 1-5
2. Barrio JR., Huang SC., Cole G., Satyamurthy N., Petric A., Phelps ME., and Small G. PET imaging of tangles and plaques in Alzheimer disease with a highly hydrophobic probe. J. Label Compd. Radiopharm. 42 (1999) S194-S195
3. Barrio, J.R., Petric, A., Satyamurthy, N., Small, G.W., Cole, G.M., Huang, S.C., 2001. Methods for labeling β-amyloid plaques and neurofibrillary tangles. US Patent No. 6274119 B1.
4. Cai L., Innis RB., and Pike VW. Radioligand development for PET imaging of β-amyloid (AB)-current status. Curr. Med. Chem. 14 (2007) 19-52
5. Cohen RM. The application of positron emitting molecular imaging tracers in Alzheimer's disease. Mol. Imaging Biol. 9 (2007) 204-216
6. Klok RP., and Windhorst AD. Residual solvent analysis by gas chromatography in radiopharmaceutical formulations containing up to 12% of ethanol. Nucl. Med. Biol. 33 (2006) 935-938
7. 18F]FDDNP) ready for animal or human administration. Mol. Imaging Biol. 9 (2007) 6-16
8. Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol. 3 (2004) 519-527
9. Shoghi-Jadid K., Small GW., Agdeppa ED., Kepe V., Ercoli LM., Siddarth P., Read S., Satyamurthy N., Petric A., Huang SC., and Barrio JR. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am. J. Geriatr. Psychiatry 10 (2002) 24-35
10. Small GW., Kepe V., Ercoli LM., Siddarth P., Bookheimer SY., Miller KJ., Lavretsky H., Burggren AC., Cole GM., Vinters HV., Thompson PM., Huang SC., Satyamurthy N., Phelps ME., and Barrio JR. PET of brain amyloid and tau in mild cognitive impairment. N. Engl. J. Med. 355 (2006) 2652-2663
11. Werner IA., Altorfer H., and Perlia X. The effectiveness of various scavengers on the γ-irradiated, methanolic solution of medazepam. Int. J. Pharm. 63 (1990) 155-166
12. Windhorst AD., Ter Linden T., De N., Keus JF., Buijs FL., Schollema PE., Van Rooij LF., and Herscheid JDM. A complete, multipurpose, low cost, fully automated and GMP compliant radiosynthesis system. J. Label Compd. Radiopharm. 44 (2001) S1052-S1054
13. Wu C., Pike VW., and Wang Y. Amyloid imaging: from benchtop to bedside. Curr. Top. Dev. Biol. 70 (2005) 171-213